JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Agilon Health (NYSE:AGL) Stock

Agilon Health (NYSE:AGL) had its price target hoisted by investment analysts at JPMorgan Chase & Co. from $31.00 to $85.00 in a report issued on Monday,Benzinga reports. The firm currently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price objective suggests a potential downside of 11.11% from the stock’s previous close.

Other equities analysts also recently issued reports about the stock. Wall Street Zen raised shares of Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Benchmark restated a “buy” rating and issued a $140.00 target price (up from $95.00) on shares of Agilon Health in a research note on Thursday, August 6th. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $146.00 target price (up from $141.00) on shares of Agilon Health in a research report on Tuesday, August 11th. Citigroup raised Agilon Health from a “sell” rating to a “neutral” rating and raised their price target for the stock from $105.00 to $115.00 in a research note on Monday, August 10th. Finally, Truist Financial set a $112.00 price target on Agilon Health and gave the stock a “hold” rating in a research note on Thursday, August 6th. Five analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Agilon Health presently has a consensus rating of “Hold” and an average price target of $97.70.

Agilon Health Price Performance

Agilon Health stock traded down $0.95 during midday trading on Monday, hitting $95.63. The company’s stock had a trading volume of 12,212 shares, compared to its average volume of 353,263. The company has a quick ratio of 1.08, a current ratio of 1.08 and a debt-to-equity ratio of 0.07. The stock’s 50-day moving average price is $105.84 and its 200-day moving average price is $61.17. Agilon Health has a 12 month low of $7.48 and a 12 month high of $133.04. The company has a market capitalization of $1.61 billion, a PE ratio of -6.70 and a beta of 3.01.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $0.14 by $0.90. The company had revenue of $1.49 billion during the quarter, compared to the consensus estimate of $1.45 billion. Agilon Health had a negative return on equity of 119.38% and a negative net margin of 3.92%. Analysts anticipate that Agilon Health will post -2.95 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

A number of institutional investors have recently made changes to their positions in AGL. LPL Financial LLC grew its position in Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after buying an additional 30,000 shares in the last quarter. CIBC Bancorp USA Inc. acquired a new position in Agilon Health in the 3rd quarter valued at approximately $34,000. Merit Financial Group LLC bought a new stake in shares of Agilon Health in the 4th quarter worth approximately $35,000. Focus Partners Advisor Solutions LLC bought a new stake in shares of Agilon Health in the 4th quarter worth approximately $53,000. Finally, Alpine Global Management LLC acquired a new stake in shares of Agilon Health during the 4th quarter worth approximately $84,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.